ERAS and pancreatic surgery: a review.
Pancreatic surgery is still considered as a high-risk abdominal surgery. While the mortality rate is low, the morbidity remains high ranging from 30 to 60%. In 2012, the ERAS study group published the official recommendations to implement the enhanced recovery after surgery (ERAS) program in patients undergoing PD. Non-randomized studies have shown that ERAS was safe and feasible. They reported a significantly shortened LOS with lower morbidity in ERAS group. However, the level of evidence remains low due to absence of randomized study and because of a substantial heterogeneity in the content of ERAS protocols. Future studies should be prospective, multicentric and designed with a structured implementation of standardized ERAS pathway.
Hospices Civils de Lyon & Lyon Sud Faculty of Medicine, UCBL1, E Herriot Hospital, Department of Digestive Surgery, 5 Place d'Arsonval, 69437, Lyon Cedex 03, France.
J
J
Perinel
Hospices Civils de Lyon & Lyon Sud Faculty of Medicine, UCBL1, E Herriot Hospital, Department of Digestive Surgery, 5 Place d'Arsonval, 69437, Lyon Cedex 03, France. mustapha.adham@chu-lyon.fr.
M
M
Adham
D006801:Humans; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000601:surgery*; D011182:Postoperative Care / Q000379:methods*; D020127:Recovery of Function
ERAS; Enhanced recovery after surgery; Pancreatectomy; Pancreatic surgery